Sigma BioScience Indonesia
PT Sigma Bioscience Indonesia is a national company specializing in the commercialization, regulatory registration, sourcing, manufacturing, and development of innovative healthcare products, including medical devices, pharmaceuticals, and technology-based bioscience products. We do not merely introduce products to the market; we build a comprehensive business ecosystem that ensures every product:
• Meets national regulatory standards
• Demonstrates clear clinical relevance
• Possesses distinct differentiation
• Remains commercially competitive
As a strategic partner for global and regional companies seeking to enter the Indonesian market, we provide end-to-end solutions—from regulatory preparation and compliance to market penetration and sustainable brand development. With a deep understanding of Indonesia’s healthcare system, PT Sigma Bioscience Indonesia ensures that every step is executed with precision, regulatory compliance, and a strong focus on addressing real clinical needs.
Sigma BioScience Indonesia
PT Sigma Bioscience Indonesia is a national company specializing in the commercialization, regulatory registration, sourcing, manufacturing, and development of innovative healthcare products, including medical devices, pharmaceuticals, and technology-based bioscience products. We do not merely introduce products to the market; we build a comprehensive business ecosystem that ensures every product:
• Meets national regulatory standards
• Demonstrates clear clinical relevance
• Possesses distinct differentiation
• Remains commercially competitiv
As a strategic partner for global and regional companies seeking to enter the Indonesian market, we provide end-to-end solutions—from regulatory preparation and compliance to market penetration and sustainable brand development. With a deep understanding of Indonesia’s healthcare system, PT Sigma Bioscience Indonesia ensures that every step is executed with precision, regulatory compliance, and a strong focus on addressing real clinical needs.
To become a trusted and leading partner in Indonesia in introducing and developing innovative healthcare products that create meaningful impact for the national healthcare system.
- To deliver innovative healthcare products with the highest standards of quality and safety.
- To become a strategic local partner for companies expanding into the Indonesian market.
- To provide end-to-end business setup services, from regulatory processes to commercialization.
- To promote the adoption of healthcare technologies driven by clinical needs and evidence-based practice.
A COMMITMENT
TO EXCEPTIONAL CARE
Demonstrates a commitment to becoming a trusted partner with a focus on innovative healthcare products that create impact on the national healthcare system.
01
Strong Regulatory Expertise
Our deep understanding of BPOM regulations, Ministry of Health policies, and national standards for distribution and manufacturing enables a more efficient, structured, and compliant registration and licensing process.
04
Extensive National Network
We maintain strong relationships and access to hospitals, clinics, distributors, and healthcare professionals across various regions in Indonesia.
02
Integrated End-to-End Approach
We manage the entire value chain—from market assessment, regulatory registration, importation or local manufacturing, distribution, to market penetration—within a fully coordinated and integrated system.
05
Focus on Clinically Differentiated Products
We are selective in partnering with products that demonstrate proven efficacy, high safety standards, and clear clinical value.
03
Experience in Medical Devices and Pharmaceuticals
Our operational and strategic capabilities are supported by hands-on experience in the medical device and pharmaceutical industries, ensuring that every product is managed in accordance with industry standards.
06
Commitment to Commercialization Success
Our role extends beyond regulatory approval—we ensure that each product is supported by a strong and sustainable market entry and commercialization strategy.
A COMMITMENT
TO EXCEPTIONAL CARE
Demonstrates a commitment to becoming a trusted partner with a focus on innovative healthcare products that create impact on the national healthcare system.
01
Strong Regulatory Expertise
Our deep understanding of BPOM regulations, Ministry of Health policies, and national standards for distribution and manufacturing enables a more efficient, structured, and compliant registration and licensing process.
02
Integrated End-to-End Approach
We manage the entire value chain—from market assessment, regulatory registration, importation or local manufacturing, distribution, to market penetration—within a fully coordinated and integrated system.
03
Experience in Medical Devices and Pharmaceuticals
Our operational and strategic capabilities are supported by hands-on experience in the medical device and pharmaceutical industries, ensuring that every product is managed in accordance with industry standards
04
Extensive National Network
We maintain strong relationships and access to hospitals, clinics, distributors, and healthcare professionals across various regions in Indonesia.
05
Focus on Clinically Differentiated Products
We are selective in partnering with products that demonstrate proven efficacy, high safety standards, and clear clinical value.
06
Commitment to Commercialization Success
Our role extends beyond regulatory approval—we ensure that each product is supported by a strong and sustainable market entry and commercialization strategy.
Contact us,
we are ready to serve you.
Email
support@sigmabioscience.co.id
Phone
(021) 8064 1063
Contact us,
we are ready to serve you.
Email
customercare@sigmabioscience.co.id
Phone
(021) 8064 1063